Research ArticleExperimental Studies

Prevention of Liver Fibrosis by the Purinoceptor Antagonist Pyridoxal-Phosphate-6-Azophenyl-2',4'-Disulfonate (PPADS)

JONATHAN A. DRANOFF, EMMA A. KRUGLOV, ODALIZ ABREU-LANFRANCO, TRONG NGUYEN, GAURAV ARORA and DHANPAT JAIN
In Vivo November 2007, 21 (6) 957-965;

Article Information

vol. 21 no. 6 957-965
PubMed 
18210741
Published By 
International Institute of Anticancer Research
Print ISSN 
0258-851X
Online ISSN 
1791-7549
History 
  • Received August 22, 2007
  • Accepted September 14, 2007
  • Published online November 1, 2007.
Copyright & License 
Copyright © 2007 The Author(s). Published by the International Institute of Anticancer Research.

Author Information

  1. JONATHAN A. DRANOFF1,2,
  2. EMMA A. KRUGLOV1,
  3. ODALIZ ABREU-LANFRANCO1,
  4. TRONG NGUYEN1,
  5. GAURAV ARORA1 and
  6. DHANPAT JAIN2
  1. 1Section of Digestive Diseases and Yale Liver Center, Yale University School of Medicine, New Haven, CT 06520
  2. 2Department of Pathology, Yale University School of Medicine, U.S.A.
  1. Correspondence to: Jonathan A. Dranoff, MD, Yale University School of Medicine, Section of Digestive Diseases, 333 Cedar St. LMP 1080, New Haven, CT 06520, U.S.A.

Statistics from Altmetric.com

Cited By...

Back to top

In this issue

Download PDF
Article Alerts
Email Article
Citation Tools
Reprints and Permissions
Prevention of Liver Fibrosis by the Purinoceptor Antagonist Pyridoxal-Phosphate-6-Azophenyl-2',4'-Disulfonate (PPADS)
JONATHAN A. DRANOFF, EMMA A. KRUGLOV, ODALIZ ABREU-LANFRANCO, TRONG NGUYEN, GAURAV ARORA, DHANPAT JAIN
In Vivo Nov 2007, 21 (6) 957-965;
Twitter logo Facebook logo Mendeley logo

Jump to section